£163.97

It has never been this cheap. We have no record of a lower price.

£164 today · cheaper than every other day in the last 3 months

Humana Hepatic Encephalopathy: Pathophysiology and Treatment: 22 (Experimental Biology and Medicine, 22)

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 36 days · 36 data points (no recent data)

Historical
Generating forecast…
£164.03 £163.96 £163.98 £163.99 £164.01 £164.02 £164.04 01 August 2026 09 August 2026 18 August 2026 27 August 2026 05 September 2026
View at Amazon ↗

Price data last checked 55 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 36 days • 1 price levels

Days at Price
36 days 0 9 18 27 36 £164 Days at Price

Price Analysis

Most common price: £164 (36 days, 100.0%)

Price range: £164 - £164

Price levels: 1 different prices over 36 days

Description

Hepatic Encephalopathy (HE) is a neuropsychiatric disorder resul t ing from liver failure. HE may be associated with fulminant (acute) hepatic failure or chronic liver disease with portal-systemic shunting. The latter condition is characterized neuropathologically by astro cytic rather than neuronal changes (Alzheimer Type II astrocytosis). The former is frequently accompanied by cerebral edema. Several hypotheses have been proposed to explain the pathogene sis of HE. These include: 1. A toxic action of a substance (or substances) such as ammonia on brain function 2. A deficit of cerebral energy metabolism 3. Neurotransmitter changes, and, more recently 4. The role of "endogenous benzodiazepines. " This volume summarizes the results of a symposium held in Val David, Quebec from October 3D-November I, 1988, that was devoted to an evaluation of the evidence for and against the various hypothe ses of HE. Data from studies in patients, in experimental (animal) models of HE, and in cultured cell preparations were discussed. In addition, a review of available approaches to the treatment and man agement of HE was included. The therapeutic use of lactulose, anti biotics, dietary treatment, and branched-chain amino acid treatments were included, as well as the results of preliminary studies of the therapeutic use of the benzodiazepine antagonist, flumazenil. Roger F. Butterworth, PhD Gilles Pomier Layrargues, MD v Acknowledgments The symposium was made possible by the generous financial assistance of: Hoffman-La Roche Ltd.

Product Specifications

Brand
Humana
Format
paperback
Domain
Amazon UK
Publication Date
17 September 2011
Listed Since
21 December 2012

Barcode

No barcode data available

Similar Products You Might Like

1,000+ Practice Questions with Rationales for Psychiatric Technician Licensure Examination
95% match

1,000+ Practice Questions with Rationales for Psychiatric Technician Licensure Examination

CREATESPACE

£87.02 18 Sep 2026
Peripheral Benzodiazepine Receptors (Neuroscience Perspectives)
94% match

Peripheral Benzodiazepine Receptors (Neuroscience Perspectives)

Elsevier

£122.78 30 Sep 2026
Benzodiazepine Receptor Ligands, Memory and Information Processing: Psychometric, Psychopharmacological and Clinical Issues: 6 (Psychopharmacology Series, 6)
94% match

Benzodiazepine Receptor Ligands, Memory and Information Processing: Psychometric, Psychopharmacological and Clinical Issues: 6 (Psychopharmacology Series, 6)

Springer

£76.47 02 Oct 2026
Sleep, Benzodiazepines and Performance: Experimental Methodologies and Research Prospects: 1 (Psychopharmacology Series, 1)
94% match

Sleep, Benzodiazepines and Performance: Experimental Methodologies and Research Prospects: 1 (Psychopharmacology Series, 1)

Springer

£76.42 01 Oct 2026
BENZODIAZEPINE: Abuse & Therapeutic Uses, Pharmacology & Health Effects (Pharmacology - Research, Safety Testing and Regulation: Substance Abuse Assessment, Interventions and Treatment)
94% match

BENZODIAZEPINE: Abuse & Therapeutic Uses, Pharmacology & Health Effects (Pharmacology - Research, Safety Testing and Regulation: Substance Abuse Assessment, Interventions and Treatment)

£142.99 30 Sep 2026
Elsevier Benzodiazepine-Based Drug Discovery Book
94% match

Elsevier Benzodiazepine-Based Drug Discovery Book

Elsevier

£148.46 05 Sep 2026
Benzodiazepines and GHB: Detection and Pharmacology (Forensic Science and Medicine)
93% match

Benzodiazepines and GHB: Detection and Pharmacology (Forensic Science and Medicine)

Humana

£80.67 25 Sep 2026
Privileged Structures in Drug Discovery - Wiley Medicinal Chemistry
93% match

Privileged Structures in Drug Discovery - Wiley Medicinal Chemistry

Wiley

£137.84 25 Sep 2026
Lawesson’s Reagent in Heterocycle Synthesis
93% match

Lawesson’s Reagent in Heterocycle Synthesis

Springer

£89.31 19 Sep 2026
β-Carbolines: A Privileged Scaffold for Modern Drug Discovery
93% match

β-Carbolines: A Privileged Scaffold for Modern Drug Discovery

CRC Press

£164.84 26 Aug 2026
Structure–Activity Relationships for Development of Neurokinin-3 Receptor Antagonists: Reducing Environmental Impact (Springer Theses)
93% match

Structure–Activity Relationships for Development of Neurokinin-3 Receptor Antagonists: Reducing Environmental Impact (Springer Theses)

Springer

£73.85 19 Sep 2026
Metals and Non-metals: Five-membered N-heterocycle Synthesis
93% match

Metals and Non-metals: Five-membered N-heterocycle Synthesis

CRC Press

£184.57 11 Sep 2026
Cycloaddition Reactions: Advances in Research and Applications
92% match

Cycloaddition Reactions: Advances in Research and Applications

£170.39 22 Aug 2026
Raney Nickel-Assisted Synthesis of Heterocycles
92% match

Raney Nickel-Assisted Synthesis of Heterocycles

Elsevier

£130.59 04 Sep 2026
Behavioral Neurobiology of GABAB Receptor Function: 52 (Current Topics in Behavioral Neurosciences, 52)
92% match

Behavioral Neurobiology of GABAB Receptor Function: 52 (Current Topics in Behavioral Neurosciences, 52)

Springer

£103.00 30 Sep 2026
Oxadiazole in Material and Medicinal Chemistry
92% match

Oxadiazole in Material and Medicinal Chemistry

CRC Press

£105.97 27 Aug 2026
Depression and Anxiety: Prevalence, Risk Factors and Treatment
92% match

Depression and Anxiety: Prevalence, Risk Factors and Treatment

£54.52 23 Sep 2026
Strategies for Resolving Individual and Family Problems
92% match

Strategies for Resolving Individual and Family Problems

Cengage Learning

£29.14 12 Sep 2026
The 2023-2028 Outlook for Benzodiazepine Drugs in the United States
92% match

The 2023-2028 Outlook for Benzodiazepine Drugs in the United States

£520.00 05 Sep 2026
Springer Biological Reactive Intermediates Vi - Book 500
92% match

Springer Biological Reactive Intermediates Vi - Book 500

Springer

£150.32 04 Sep 2026
Springer Staging Neuropsychiatric Disorders Medical Book
92% match

Springer Staging Neuropsychiatric Disorders Medical Book

Springer

£107.47 03 Oct 2026
Development of Tolerance and Dependence in Barbiturate Use
92% match

Development of Tolerance and Dependence in Barbiturate Use

LAP Lambert Academic Publishing

£42.00 25 Sep 2026
McGraw-Hill Poisoning and Drug Overdose, 8th Edition Guide
92% match

McGraw-Hill Poisoning and Drug Overdose, 8th Edition Guide

McGraw-Hill Education

£70.57 26 Sep 2026
Biological Reactive Intermediates Vi: Chemical and Biological Mechanisms in Susceptibility to and Prevention of Environmental Diseases: 500 (Advances in Experimental Medicine and Biology, 500)
92% match

Biological Reactive Intermediates Vi: Chemical and Biological Mechanisms in Susceptibility to and Prevention of Environmental Diseases: 500 (Advances in Experimental Medicine and Biology, 500)

Springer

£60.43 07 Sep 2026